Altered expression of lymphocyte differentiation antigens on phorbol ester-activated CD4+8+ T cells. 1988

E R Richie, and B McEntire, and J Phillips, and J P Allison
University of Texas System Cancer Center, Science Park-Research Division, Smithville 78957.

Altered expression of cell surface Ag is an early event accompanying Ag-, mitogen-, or phorbol ester-induced activation of mature T cells. In this report, phorbol ester-induced changes in the expression of several functionally significant cell surface molecules are explored on immature thymocytes and lymphoma cells presenting a cortical CD4+8+ double-positive (DP) phenotype. Both CD4 and CD8 expressions are down-modulated on DP cells incubated with PMA. Cell-surface expression of CD4 and CD8 remains depressed for 72 h in the presence of PMA, but is restored after removal of PMA from the culture medium. The PMA-mediated loss of Ag expression is associated with a rapid down-regulation of steady state CD4 and CD8 mRNA transcript levels in treated cells. The sustained loss of CD4 and CD8 surface expression on DP cells is a selective event because CD5 expression is enhanced, H-2 expression is unchanged, and CD3 expression is only transiently diminished by PMA stimulation. Other T cell-activating agents, including Con A, ionomycin, and anti-CD3 mAb, induce selected surface antigenic changes on DP cells, but do not mimic the pattern of altered Ag expression observed after PMA stimulation. These data demonstrate that, similar to mature subsets, T cells in the DP nonmature compartment undergo alterations in expression of functionally important cell-surface molecules in response to activating agents. Nevertheless, distinctions between mature and nonmature T cells regarding specific alterations in differentiation Ag phenotype suggest that the effect of PMA on expression of these molecules depends, in part, on the maturation stage of the target cell population.

UI MeSH Term Description Entries
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008223 Lymphoma A general term for various neoplastic diseases of the lymphoid tissue. Germinoblastoma,Lymphoma, Malignant,Reticulolymphosarcoma,Sarcoma, Germinoblastic,Germinoblastic Sarcoma,Germinoblastic Sarcomas,Germinoblastomas,Lymphomas,Lymphomas, Malignant,Malignant Lymphoma,Malignant Lymphomas,Reticulolymphosarcomas,Sarcomas, Germinoblastic
D008806 Mice, Inbred AKR An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. Mice, AKR,Mouse, AKR,Mouse, Inbred AKR,AKR Mice,AKR Mice, Inbred,AKR Mouse,AKR Mouse, Inbred,Inbred AKR Mice,Inbred AKR Mouse
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D004587 Electrophoresis, Agar Gel Electrophoresis in which agar or agarose gel is used as the diffusion medium. Electrophoresis, Agarose Gel,Agar Gel Electrophoresis,Agarose Gel Electrophoresis,Gel Electrophoresis, Agar,Gel Electrophoresis, Agarose
D000276 Adjuvants, Immunologic Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund's adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. Immunoactivators,Immunoadjuvant,Immunoadjuvants,Immunologic Adjuvant,Immunopotentiator,Immunopotentiators,Immunostimulant,Immunostimulants,Adjuvant, Immunologic,Adjuvants, Immunological,Immunologic Adjuvants,Immunological Adjuvant,Adjuvant, Immunological,Immunological Adjuvants
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000945 Antigens, Differentiation, T-Lymphocyte Antigens expressed on the cell membrane of T-lymphocytes during differentiation, activation, and normal and neoplastic transformation. Their phenotypic characterization is important in differential diagnosis and studies of thymic ontogeny and T-cell function. Antigens, Differentiation, T-Cell,Differentiation Antigens, T-Cell,L3T4 Antigens,Leu Antigens, T-Lymphocyte,T-Cell Differentiation Antigens,T-Lymphocyte Differentiation Antigens,T6 Antigens,Antigens, Differentiation, T Lymphocyte,Differentiation Antigens, T Lymphocyte,Antigens, L3T4,Antigens, T-Cell Differentiation,Antigens, T-Lymphocyte Differentiation,Antigens, T-Lymphocyte Leu,Antigens, T6,Differentiation Antigens, T Cell,Differentiation Antigens, T-Lymphocyte,Leu Antigens, T Lymphocyte,T Cell Differentiation Antigens,T Lymphocyte Differentiation Antigens,T-Lymphocyte Leu Antigens
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated

Related Publications

E R Richie, and B McEntire, and J Phillips, and J P Allison
November 1981, Cellular immunology,
E R Richie, and B McEntire, and J Phillips, and J P Allison
April 1995, The Journal of experimental medicine,
E R Richie, and B McEntire, and J Phillips, and J P Allison
March 1986, European journal of immunology,
E R Richie, and B McEntire, and J Phillips, and J P Allison
July 1988, Biochimie,
E R Richie, and B McEntire, and J Phillips, and J P Allison
January 1989, Archivum immunologiae et therapiae experimentalis,
E R Richie, and B McEntire, and J Phillips, and J P Allison
April 1996, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research,
E R Richie, and B McEntire, and J Phillips, and J P Allison
June 1988, Bratislavske lekarske listy,
E R Richie, and B McEntire, and J Phillips, and J P Allison
December 1975, Israel journal of medical sciences,
E R Richie, and B McEntire, and J Phillips, and J P Allison
April 1985, Journal of immunology (Baltimore, Md. : 1950),
E R Richie, and B McEntire, and J Phillips, and J P Allison
November 1996, Immunology letters,
Copied contents to your clipboard!